HLA-G protein expression is not induced during malignant transformation

Tissue Antigens

Volumn 53, Issue 4 I, 1999, Pages 335-346

  Pangault, C ^a   Amiot, L ^a   Caulet Maugendre, S ^b   Brasseur, F ^c   Burtin, F ^b   Guilloux, V ^a   Drenou, B ^a   Fauchet, R ^a   Onno, Myriam ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

Author keywords

Dendritic cell; HLA G antigen; Immunoregulation; Lung carcinoma; Macrophage; Solid tumor

Indexed keywords

HLA G ANTIGEN; TUMOR MARKER;

ALTERNATIVE RNA SPLICING; ANTIGEN EXPRESSION; ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; CANCER CELL; CHORIOCARCINOMA; COLON CANCER; CONTROLLED STUDY; DENDRITIC CELL; EFFECTOR CELL; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; KIDNEY CANCER; LARYNX CANCER; LIVER CANCER; LUNG CANCER; MACROPHAGE; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; MONONUCLEAR PHAGOCYTE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOLID TUMOR; TUMOR BIOPSY; TUMOR CELL LINE;

CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; NEOPLASMS;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0032713545     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.1999.530403.x     Document Type: Article

References (41)

1. Le Bouteiller P. HLA-G: on the tract of imnmnological functions. Eur J Immunogenet 1997: 24: 397-408.
2. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R. A class I antigen, HLA-G expressed in human trophoblasts. Science 1990: 248: 220-3.
3. Loke YW, King A, Burrows T et al. Evaluation of trophoblast HLA-G antigen with a specific monoclonal antibody. Tissue Antigens 1997: 50: 135-46.
4. Onno M, Guillaudeux T, Amiot L et al. The HLA-G gene is expressed at a low mRNA level in different human cells and tissues. Hum Immunol 1994: 41: 79-86.
5. Amiot L, Onno M, Renard I et al. HLA-G transcription studies during the different stages of normal and malignant hematopoicsis. Tissue Antigens 1996: 48: 609-14.
6. Amiot L, Onno M, Drénou B, Monvoisin C, Fauchet R, HLA-G class I gene expression in normal and malignant hematopoietic cells. Hum Immunol 1998: 59: 524-8.
7. Crisa L, McMaster MT, Ishii JK, Fisher SJ, Salomon DR. Identification of a thymie epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. J Exp Med 1997: 186: 289-98.
8. Münz C, Holmes N, King A et al. Human histocomptability leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells. J Exp Med 1997: 185: 385-91.
9. Cantoni C, Verdiani S, Falco M et al. p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily. Eur J Immunol 1998: 28: 1980-90.
10. Colonna M, Samaridis J, Cella M et al. Human myelomonoeytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol 1998: 160: 3096-4100.
11. Lee N, Goodlett DR, Ishitani A, Marquardt H, Geraghty DE. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J Immunol 1998: 160: 4951-60.
12. Borrego F, Ulbrecht M, Weiss EH, Coligan JE, Brooks AG. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/ NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med 1998: 187: 813-8.
13. Lee N, Malacko AR, Ishitani A et al. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 1995: 3: 1-20.
14. Diehl M, Münz C, Keilholz W et al. Nonclassical HLA-G molecules are classical peptide presenters. Curr Biol 1996: 6: 305-14.
15. Amiot L, Onno M, Lamy T et al. Loss of HLA molecules in B lymphomas is associated with an agressive behavior. Brit J Haematol 1998: 100: 655-63.
16. Marincola FM, Shamamian P, Alexander RB et al. Loss of HLA haplotype and B locus down-regulation in melanoma cell lines. J Immunol 1994: 153: 1225-37.
17. Luboldt HJ, Kubens BS, Rubben H, Grosse-Wilde H, Selective loss of human leukocyte antigen class I allele expression in advanced renal cell carcinoma. Cancer Res 1996: 56: 826-30.
18. Concha A, Esteban F, Cabrera T, Ruiz-Cabello F, Carrido F, Tumor aggresiveness and MHC class I and II antigens in laryngeal and breast cancer. Semin Cancer Biol 1991: 2: 47-54.
19. Ruiz-Cabello F, Garrido F. HLA and cancer: from research to clinical impact. Immunol Today 1998: 19: 539-12.
20. Joh T, Yamada Y, Seto M, Kamihira S, Tomonaga M. Expression of CD8beta and alteration of cell surface phenotype in adult T-cell leukemia cells. Br J Haematol 1997: 98: 151-6.
21. Gonzalez-Campora R, Garda-Santana JA, Jorda I et al. Blood group antigens in differentiated thyroid neoplasms. Arch Pathol Lab Med 1998: 122: 957-65.
22. Kim WH, Lee BL, Jun SH, Song SY, Kleinman HK. Expression of 32/67 kDa laminin receptor in laminin adhesion-selected human colon cancer cell lines. Br J Cancer 1998: 77: 15-20.
23. Yang Y, Chu W, Geraghty DE, Hunt JS. Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-γ. J Immunol 1996: 156: 4224-31.
24. Paul P, Rouas-Freiss N, Kahlil-Daher I et al. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci U S A 1998: 95: 4510-5.
25. Frumento G, Franchello S, Geraghty E, Ferrara GB. Analysis of HLA-G expression in tumor cell lines. First International Conference on HLA-G, July 6-7, 1998, Paris, France.
26. Maier S, Weiss E. Expression and regulation of HLA-G in human glioma cell lines. First International Conference on HLA-G, July 6-7, 1998, Paris, France.
27. Weynants P, Wauters P, Coulie PG, Van den Eynde B, Symann M, Boon T. Cytolytic response of human T cells against allogeneic small cell lung carcinoma treated with interferon gamma. Cancer Immunol Immunother 1988: 27: 228-32.
28. Brändie D, Brasseur F, Weynants P, Boon T, Van den Eynde BJ. A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal carcinoma. J Exp Med 1996: 183: 2501-8.
29. Mandruzzato S, Brasseur F, Andry G, Boon T, van der Bruggen P. A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma. J Exp Med 1997: 186: 785-93.
30. Kirszenbaum M, Moreau P, Gluckman E, Dausset J, Carosella E. An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. Proc Natl Acad Sci U S A 1994: 91: 4209-13.
31. Fujii T, Ishitani A, Geraghty DE. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol 1994: 153: 5516-24.
32. Soule HD, Vazguez J, Long A, Albert S, Brunnan M. A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 1973: 51: 1409-16.
33. Berkowitz RS, Paris HM, Hill JA, Anderson DJ. Localization of leukocytes and cytokines in chorionic villi of normal placentas and complete hydatiform moles. Gynecol Oncol 1990: 37: 396-400.
34. Garcia-Lloret MI, Morrish DW, Wegmann TG, Honore L, Turner AR, Guilbert LJ. Demonstration of functional cytokine-placental interactions: CSF-1 and GM-CSF stimulate human cytotrophoblast differentiation and peptide hormone secretion. Exp Cell Res 1994: 214: 46-54.
35. Blaschiltz A, Lenfant F, Mallet V et al. Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G. Eur J Immunol 1997: 27: 3380-8.
36. Chu W, Fant ME, Geraghty ED, Hunt JS. Soluble HLA-G in human placentas: synthesis in trophoblasts and interferon-γ-activated macrophages but not placental fibroblasts. Human Immunology 1998: 59: 435-42,
37. Tarr PE. Granulocyte-macrophage colony-stimulating factor and the immune system, Med Oncol 1996: 3: 133-40.
38. Tazi A, Bouchonnet F, Grandsaigne M, Boumsell L, Hance AJ, Soler P. Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/ Langerhans cells in human lung and lung cancers. J Clin Invest 1993: 91: 566-76.
39. Odum N, Ledbetter JA, Martin P et al. Homotypic aggregation of human cell lines by HLA class II-, class Ia-and HLA-G-specific monoclonal antibodies. Eur J Immunol 1991: 21: 2121-31.
40. Maejima M, Fujii T, Kozuma S, Okai T, Shibata Y, Taketani Y. Presence of HLA-G expressing cells modulates the ability of peripheral blood mononuclear cells to release cytokines. Am J Reprod Immunol 1997: 38: 79-82.
41. Guilbert L, Robertson SA, Wegmann TG. The trophoblast as an integral component of a macrophage-cytokine network, Immunol Cell Biol 1993: 71: 49-57.